BioCentury
ARTICLE | Company News

Orion Pharma, Population Council deal

April 24, 2000 7:00 AM UTC

The council will grant Orion exclusive worldwide rights to develop, commercialize and sublicense Nestorone synthetic progestin in transdermal dosage forms other than the patch for hormone replacement ...